Cat.#: ACPP-1292
| Despition | Nkx2.2 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1375 | Human GABARAPL1 Protein (AC1375) | 5 µg | inquiry |
| ACPP-1672 | Human SERPINA3 Protein (AC1672) | 20 µg | inquiry |
| ACPP-1206 | ELOVL4 Blocking Peptide (AC1206) | 250 µg | inquiry |
| ACPP-1249 | TMPRSS2 Blocking Peptide (AC1249) | 250 µg | inquiry |
| ACPP-1842 | Mouse TIMP1 (AC1842) | 2 µg | inquiry |
| ACPP-1408 | Human SH3GL3 Protein (AC1408) | 5 µg | inquiry |
| ACPP-1262 | CXCR4 Blocking Peptide (AC1262) | 250 µg | inquiry |
| ACPP-1484 | Human CPE Protein (AC1484) | 5 µg | inquiry |
| ACPP-1567 | Human EFNB2 Protein (AC1567) | 5 µg | inquiry |
| ACPP-1720 | Human PNPO Protein (AC1720) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.